Literature DB >> 21321395

Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance.

Kenneth Hensley1, Lisa L Barnes, Alexandar Christov, Christy Tangney, William G Honer, Julie A Schneider, David A Bennett, Martha Clare Morris.   

Abstract

Ventricular cerebrospinal fluid (vCSF) obtained at autopsy from 230 participants in the Religious Orders Study was analyzed for alpha tocopherol (αT, vitamin E) and gamma tocopherol (γT) in relation to brain tissue neuropathological diagnoses (NIA-Reagan criteria); neuritic plaque density and neurofibrillary tangle state (Braak stage); and cognitive function proximate to death. Neither vCSF αT nor γT was related to the pathological diagnosis of Alzheimer's disease, but vCSF αT concentration was inversely related to neuritic plaque density (β = -0.21, SE = 0.105, p = 0.04) in regression models adjusted for age, gender, education, and APOE-4. Ventricular CSF αT concentration was positively associated with perceptual speed (β = 0.27, SE = 0.116, p = 0.02) whereas the γT/αT ratio was negatively associated with episodic memory (β = -0.037, SE = 0.017, p = 0.04). Only vCSF αT, but not γT, was correlated with postmortem interval (PMI). Adjustment for PMI had no effect on significance of associations between αT and perceptual speed or γT/αT and episodic memory, but after this adjustment the αT concentration was no longer significantly associated with neuritic plaques. These data suggest that vCSF αT, but not γT, is weakly associated with less Alzheimer's disease neuropathology, specifically neuritic plaques, and correlates with better performance on tests of perceptual speed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321395      PMCID: PMC3160276          DOI: 10.3233/JAD-2011-101995

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  37 in total

1.  Relation of cerebral infarctions to dementia and cognitive function in older persons.

Authors:  J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

2.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

Authors:  Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

3.  Increased lipoprotein oxidation in Alzheimer's disease.

Authors:  S Schippling; A Kontush; S Arlt; C Buhmann; H J Stürenburg; U Mann; T Müller-Thomsen; U Beisiegel
Journal:  Free Radic Biol Med       Date:  2000-02-01       Impact factor: 7.376

4.  The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain.

Authors:  Kelly S Williamson; S Prasad Gabbita; Shenyun Mou; Melinda West; Quentin N Pye; William R Markesbery; Robert V Cooney; Paula Grammas; Ulrich Reimann-Philipp; Robert A Floyd; Kenneth Hensley
Journal:  Nitric Oxide       Date:  2002-03       Impact factor: 4.427

5.  Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats.

Authors:  Qing Jiang; Bruce N Ames
Journal:  FASEB J       Date:  2003-05       Impact factor: 5.191

6.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

7.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

8.  Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Neelum Aggarwal; Robert S Wilson; Paul A Scherr
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

9.  Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.

Authors:  M G Traber; G W Burton; L Hughes; K U Ingold; H Hidaka; M Malloy; J Kane; J Hyams; H J Kayden
Journal:  J Lipid Res       Date:  1992-08       Impact factor: 5.922

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  16 in total

Review 1.  Antioxidants in the canine model of human aging.

Authors:  Amy L S Dowling; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

Review 2.  Therapeutic potential of vitamin E and its derivatives in traumatic brain injury-associated dementia.

Authors:  Jan Dobrovolny; Martin Smrcka; Julie Bienertova-Vasku
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

3.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  Vitamin E inadequacy in humans: causes and consequences.

Authors:  Maret G Traber
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

5.  Brain tocopherols related to Alzheimer's disease neuropathology in humans.

Authors:  Martha Clare Morris; Julie A Schneider; Hong Li; Christy C Tangney; Sukriti Nag; David A Bennett; William G Honer; Lisa L Barnes
Journal:  Alzheimers Dement       Date:  2014-02-28       Impact factor: 21.566

Review 6.  Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis.

Authors:  Katie M Lebold; Maret G Traber
Journal:  Free Radic Biol Med       Date:  2013-08-03       Impact factor: 7.376

7.  Vitamin E is essential for Purkinje neuron integrity.

Authors:  L Ulatowski; R Parker; G Warrier; R Sultana; D A Butterfield; D Manor
Journal:  Neuroscience       Date:  2013-12-14       Impact factor: 3.590

8.  Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.

Authors:  Rukhsana Sultana; Mauro Baglioni; Roberta Cecchetti; Jian Cai; Jon B Klein; Patrizia Bastiani; Carmelinda Ruggiero; Patrizia Mecocci; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2013-08-08       Impact factor: 7.376

Review 9.  Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease.

Authors:  Giorgio La Fata; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2014-11-28       Impact factor: 5.717

10.  Brain amyloid-β oligomers in ageing and Alzheimer's disease.

Authors:  Sylvain E Lesné; Mathew A Sherman; Marianne Grant; Michael Kuskowski; Julie A Schneider; David A Bennett; Karen H Ashe
Journal:  Brain       Date:  2013-04-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.